News & Analysis on Clinical Trial Services & Contract Research And Development
For the past 10 years, drug companies have paid the US Food and Drug Administration (FDA) fees to review each drug they want approved, on the grounds that the increased funding for the agency would accelerate review times and shorten the time to...
The executive chairman of UK-based drug delivery specialist SkyePharma, Ian Gowrie-Smith, will step down at the firm's next annual general meeting in 2004 and seek reappointment as non-executive chairman.
The Indian government has proposed draconian new penalties for individuals found making counterfeit pharmaceuticals, after a number of fatalities associated with bootleg drugs.